These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Post-herpetic pseudolymphoma in chronic lymphoid leukemia]. Crickx B; Grossin M; Fermand JP; Belaïch S Ann Dermatol Venereol; 1990; 117(11):892-3. PubMed ID: 2099717 [No Abstract] [Full Text] [Related]
9. Cutaneous pseudolymphoma following quadrivalent human papillomavirus vaccination - a rare adverse event. Ramos Pinheiro R; Duarte B; João A; Lencastre A J Dtsch Dermatol Ges; 2018 Apr; 16(4):465-467. PubMed ID: 29521018 [No Abstract] [Full Text] [Related]
10. Cutaneous pseudolymphoma localized to black tattoo. Campolmi P; Bassi A; Bonan P; Cannarozzo G; Gola M; Rossi Degl'Innocenti D; Lotti T; Massi D J Am Acad Dermatol; 2011 Nov; 65(5):e155-7. PubMed ID: 22000890 [No Abstract] [Full Text] [Related]
11. Cutaneous Pseudolymphoma Due to Hirudotherapy. Temiz SA; Özer İ; Ataseven A; Dursun R; Fındık S Turkiye Parazitol Derg; 2019 Mar; 43(1):50-52. PubMed ID: 30938141 [TBL] [Abstract][Full Text] [Related]
12. Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma. Singletary HL; Selim MA; Olsen E Arch Dermatol; 2012 May; 148(5):572-4. PubMed ID: 22782150 [No Abstract] [Full Text] [Related]
13. [Cutaneous pseudolymphoma as an alternative presentation of IgG4 related disease]. Eddou H; Le Guyadec T; Cremades A; Saint Blancard P; Malfuson JV; Konopacki J; de Revel T Ann Biol Clin (Paris); 2013; 71(3):333-7. PubMed ID: 23747671 [TBL] [Abstract][Full Text] [Related]